An overview of radiotracers in nuclear cardiology.

作者信息

Acampa W, Di Benedetto C, Cuocolo A

机构信息

Nuclear Medicine Center of the National Council of Research, Department of Biomorphological and Functional Sciences, University Federico II, Naples, Italy.

出版信息

J Nucl Cardiol. 2000 Nov-Dec;7(6):701-7. doi: 10.1067/mnc.2000.109969.

DOI:10.1067/mnc.2000.109969

PMID:11144485

Abstract

摘要

相似文献

An overview of radiotracers in nuclear cardiology.

J Nucl Cardiol. 2000 Nov-Dec;7(6):701-7. doi: 10.1067/mnc.2000.109969.

Absolute quantitation of myocardial blood flow: the technical and clinical prospects for single-photon emission computed tomography.

J Nucl Cardiol. 1996 Nov-Dec;3(6 Pt 2):S60-5. doi: 10.1016/s1071-3581(96)90209-3.

Myocardial perfusion imaging agents: SPECT and PET.

J Nucl Cardiol. 2004 Jan-Feb;11(1):71-86. doi: 10.1016/j.nuclcard.2003.12.002.

Blood flow and metabolism by PET.

Cardiol Clin. 1994 May;12(2):303-15.

Nuclear medicine studies of the heart.

Eur Radiol. 1998;8(9):1698-706. doi: 10.1007/s003300050616.

[Positron emission tomography (PET)].

Nihon Rinsho. 2003 Apr;61 Suppl 4:377-86.

Steps forward in the assessment of myocardial viability in left ventricular dysfunction.

Circulation. 1998 Mar 10;97(9):833-8. doi: 10.1161/01.cir.97.9.833.

[Scintigraphy and positron emission tomography].

Ther Umsch. 1997 Dec;54(12):711-21.

Tracer kinetic modeling in nuclear cardiology.

J Nucl Cardiol. 2000 Nov-Dec;7(6):686-700. doi: 10.1067/mnc.2000.111127.

Comparison of Tl-201 with Tc-99m-labeled myocardial perfusion agents: technical, physiologic, and clinical issues.

J Nucl Cardiol. 2001 Jul-Aug;8(4):482-98. doi: 10.1067/mnc.2001.115078.

引用本文的文献

Combined evaluation of CAC score and myocardial perfusion imaging in patients at risk of cardiovascular disease: where are we and what do the data say.

J Nucl Cardiol. 2023 Dec;30(6):2349-2360. doi: 10.1007/s12350-023-03288-2. Epub 2023 May 10.

Technetium-99m Radiopharmaceuticals for Ideal Myocardial Perfusion Imaging: Lost and Found Opportunities.

Molecules. 2022 Feb 10;27(4):1188. doi: 10.3390/molecules27041188.

Effect of co-ligands on chemical and biological properties of (99m)Tc(III) complexes [(99m)Tc(L)(CDO)(CDOH)2BMe] (L=Cl, F, SCN and N3; CDOH2=cyclohexanedione dioxime).

Nucl Med Biol. 2014 Nov-Dec;41(10):813-24. doi: 10.1016/j.nucmedbio.2014.07.009. Epub 2014 Aug 1.

Development of kit formulations for (99m) TcN-MPO: a cationic radiotracer for myocardial perfusion imaging.

J Labelled Comp Radiopharm. 2014 Jul;57(9):584-92. doi: 10.1002/jlcr.3221. Epub 2014 Jul 28.

64Cu-labeled phosphonium cations as PET radiotracers for tumor imaging.

Bioconjug Chem. 2011 Aug 17;22(8):1459-72. doi: 10.1021/bc200106p. Epub 2011 Jul 1.

Minimizing liver uptake of cationic Tc radiotracers with ether and crown ether functional groups.

World J Hepatol. 2010 Jan 27;2(1):21-31. doi: 10.4254/wjh.v2.i1.21.

Evaluation of (99) (m)TcN-MPO as a new myocardial perfusion imaging agent in normal dogs and in an acute myocardial infarction canine model: comparison with (99) (m)Tc-sestamibi.

Mol Imaging Biol. 2011 Feb;13(1):121-7. doi: 10.1007/s11307-010-0304-2.

Mechanism for myocardial localization and rapid liver clearance of Tc-99m-N-MPO: a new perfusion radiotracer for heart imaging.

J Nucl Cardiol. 2009 Jul-Aug;16(4):571-9. doi: 10.1007/s12350-009-9068-y. Epub 2009 Mar 14.

64Cu-labeled 2-(diphenylphosphoryl)ethyldiphenylphosphonium cations as highly selective tumor imaging agents: effects of linkers and chelates on radiotracer biodistribution characteristics.

Bioconjug Chem. 2008 Oct;19(10):2008-22. doi: 10.1021/bc8002056. Epub 2008 Sep 3.

Tc-99m-N-MPO: novel cationic Tc-99m radiotracer for myocardial perfusion imaging.

J Nucl Cardiol. 2008 Jul-Aug;15(4):535-46. doi: 10.1016/j.nuclcard.2008.02.022. Epub 2008 Apr 21.

本文引用的文献

Quantitative thallium-201 and technetium 99m sestamibi tomography at rest in detection of myocardial viability in patients with chronic ischemic left ventricular dysfunction.

J Nucl Cardiol. 2000 Jan-Feb;7(1):8-15. doi: 10.1067/mnc.2000.100706.

Identification of viable myocardium in patients with chronic coronary artery disease using rest-redistribution thallium-201 tomography: optimal image analysis.

J Nucl Med. 1998 Nov;39(11):1869-74.

Rest-redistribution thallium-201 SPECT to detect myocardial viability.

J Nucl Med. 1998 Mar;39(3):384-90.

Prognostic value of myocardial hypoperfusion indexes in patients with suspected or known coronary artery disease.

J Nucl Cardiol. 1994 Jul-Aug;1(4):325-37. doi: 10.1007/BF02939954.

Technetium-99m-1,2-bis[bis(2-ethoxyethyl) phosphino]ethane: human biodistribution, dosimetry and safety of a new myocardial perfusion imaging agent.

J Nucl Med. 1993 Jan;34(1):30-8.

Independent and incremental prognostic value of exercise single-photon emission computed tomographic (SPECT) thallium imaging in coronary artery disease.

J Am Coll Cardiol. 1993 Sep;22(3):665-70. doi: 10.1016/0735-1097(93)90174-y.

Biokinetics of technetium-99m-tetrofosmin: myocardial perfusion imaging agent: implications for a one-day imaging protocol.

J Nucl Med. 1993 Aug;34(8):1254-9.

Fatty acid-binding protein and its relation to fatty acid oxidation.

Mol Cell Biochem. 1993;123(1-2):101-6. doi: 10.1007/BF01076480.

Comparison of myocardial perfusion imaging with technetium-99m tetrofosmin versus thallium-201 in coronary artery disease.

Am J Cardiol. 1993 Nov 1;72(14):1015-9. doi: 10.1016/0002-9149(93)90855-7.

Predicting recovery of severe regional ventricular dysfunction. Comparison of resting scintigraphy with 201Tl and 99mTc-sestamibi.

Circulation. 1994 Jun;89(6):2552-61. doi: 10.1161/01.cir.89.6.2552.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验